Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Helen S. Kim

Helen S. Kim is recorded as Board Member at Prothena Corp Public Ltd Co (PRTA) and Board Member at Assembly Biosciences, Inc. (ASMB). Helen S. Kim was last confirmed as Board Member at Exicure, Inc. (XCUR) in a filing dated April 21, 2020. Aktis Oncology, Inc. reported in an 8-K filed April 16, 2026 that Helen S. Kim resigned as member of the Board and all committees thereof, effective May 20, 2026. Prothena Corp Public Ltd Co reported in an 8-K filed September 1, 2022 that Helen S. Kim was appointed director, effective August 30, 2022.

“On April 15, 2026, each of Helen S. Kim and Oleg Nodelman notified the Board of their decision to resign from their respective positions as members of the Board and all committees thereof, effective as of May 20, 2026.”
Aktis Oncology, Inc. Form 8-K, filed April 16, 2026 · Read the filing
“On August 30, 2022, the Board of Directors (the "Board") of Prothena Corporation plc (the "Company") increased the size of the Board and appointed Helen S. Kim to serve as a director of the Company, effective immediately.”
Prothena Corp Public Ltd Co Form 8-K, filed September 1, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Assembly Biosciences, Inc.

Other people whose current roles at this company are on record from its filings.

Leadership on record at Prothena Corp Public Ltd Co

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.